Cargando…
Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia
BACKGROUND: Vascular dementia (VaD) is the most severe manifestation of cognitive impairment caused by cerebrovascular disease. There are currently no specific drug treatments approved for VaD, with cholinesterase inhibitors (AChEI) being frequently used in VaD. However, the benefits they provide ar...
Autores principales: | García-Alberca, José María, Mendoza, Silvia, Gris, Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106639/ https://www.ncbi.nlm.nih.gov/pubmed/35349093 http://dx.doi.org/10.1007/s40261-022-01136-8 |
Ejemplares similares
-
Combined treatment with Ginkgo biloba extract EGb 761 plus acetylcholinesterase inhibitors improved cognitive function and neuropsychiatric symptoms in patients with mild cognitive impairment
por: García‐Alberca, José María, et al.
Publicado: (2022) -
Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761(®))
por: Tomino, Carlo, et al.
Publicado: (2021) -
The Effect of Ginkgo Biloba (EGb 761) on Epileptic Activity in Rabbits
por: Ivetic, Vesna, et al.
Publicado: (2008) -
The Ginkgo biloba Extract EGb 761 Modulates Proteasome Activity and Polyglutamine Protein Aggregation
por: Stark, Marcel, et al.
Publicado: (2014) -
Ginkgo biloba leaf extract EGb 761(®) as a paragon of the product by process concept
por: Kulić, Žarko, et al.
Publicado: (2022)